Rokit Healthcare

Rokit Healthcare develops regenerative-medicine treatments, therapies that aim to repair or regrow damaged tissue, targeting conditions such as diabetic foot ulcers, chronic wounds, cartilage damage from osteoarthritis, and chronic kidney disease.

Its products are intended for use in clinical and hospital settings, addressing patients where standard treatments such as dressings, injections, or dialysis fall short. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company's platform is built around bioprinting and tissue-engineering technology applied across multiple therapeutic areas rather than a single product line.